Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2018

01-01-2018 | Correspondence

Diagnostic and Prognostic Value of Serum Thymidine Kinase 1 in Cancer Patients

Authors: Yantao Li, Rongna Wei, Shilin Song

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2018

Login to get access

Excerpt

Once tumorigenic factors induce abnormal cells’ growth, they grow indefinitely without physiological regulations [1‐3]. Studies found serum thymidine kinase 1 (TK1) level of cancer patients deviates to a certain extent from normal [4, 5]. It is possible that serum TK1 level can be used in cancers’ diagnosis and prognosis. Our study aimed to explore related viewpoint via a clinical controlled trial. …
Literature
1.
Kamran SC, Howard SA, Shinagare AB et al (2013) Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol 39(1):46–52CrossRefPubMed
2.
Xie L, Fan M, Sheets NC et al (2012) The use of radiation therapy appears to improve outcome in patients with malignant primary tracheal tumors: a SEER-based analysis. Int J Radiat Oncol Biol Phys 84(2):464–470CrossRefPubMed
3.
Benz MR, Czernin J, Allen-Auerbach MS et al (2012) 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response. Cancer 118(12):3135–3144CrossRefPubMed
4.
Bolayirli M, Papila C, Korkmaz GG et al (2013) Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy. J Clin Lab Anal 27(3):220–226CrossRefPubMed
5.
Nisman B, Allweis T, Kadouri L et al (2013) Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients. Clin Chem Lab Med: CCLM 51(2):439–447CrossRefPubMed
6.
Zhou J, Zhang W, Yang W, Wang X, Li F (2015) Effect of S-1 on serum TK1, VEGF, IGF-1 and tumor biomarkers, estrgen levels in patients with advanced breast cancer. Chin J Biochem Pharm 35(8):69–71
7.
Xiaojun T, Guiming C, Xiaohong F, Yefu S (2012) Clinical value of combined detection of serum TK1, TPS and CA15-3 in diagnosis of breast cancer. Int J Lab Med 33(16):1943–1944, 1946
8.
Liu M, Deng Y, Liu P (2012) Value of joint detection of serum SCC-Ag, VEGF, IGF-II and TK1 in the diagnosis of early stage cervical cancer. Hainan Med J 23(13):91–93
9.
Huang MY, Wu CH, Huang CM et al (2013) DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy. Biomed Res Int 2013. doi:10.​1155/​2013/​931028
10.
Schelhaas S, Wachsmuth L, Viel T et al (2014) Variability of proliferation and diffusion in different lung cancer models as measured by 3′-deoxy-3′-18F-fluorothymidine PET and diffusion-weighted MR imaging. J Nucl Med 55(6):983–988CrossRefPubMed
Metadata
Title
Diagnostic and Prognostic Value of Serum Thymidine Kinase 1 in Cancer Patients
Authors
Yantao Li
Rongna Wei
Shilin Song
Publication date
01-01-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0812-1

Other articles of this Issue 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Go to the issue

Original Article

Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact

Correspondence

Florid Plasmacytosis in Angioimmunoblastic T Cell Lymphoma: A Diagnostic Conundrum

Original Article

C-Window Peaks on CE-HPLC are Extremely Rare in Northern India, and Only Infrequently Represent HbC

Correspondence

Leukocyte Cell Population Data Provide Clues for Myelodysplastic Syndrome in a 79-Year-old Male

Short Communication

Summary and Review of the Abstracts on Disorders of Red Cells and Erythropoiesis Presented at Haematocon 2016–2017

Correspondence

Diagnostic Dilemma in Ambiguous Lineage Acute Leukemia: A Case Report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits